Related Experiment Videos
Hypertension after liver transplantation
S C Textor1, V J Canzanello, S J Taler
1Division of Hypertension, Mayo Clinic, Rochester, MN 55905, USA.
Insights
Post-liver transplant hypertension is common, driven by factors like altered vascular function and medication side effects. Early recognition and management are crucial for reducing long-term cardiovascular risks in recipients.
Area of Science:
- Nephrology
- Cardiology
- Transplantation Medicine
Background:
- Hypertension is a near-universal complication following liver transplantation.
- Several pathogenic mechanisms contribute to post-transplant hypertension.
Purpose of the Study:
- To elucidate the mechanisms underlying hypertension after liver transplantation.
- To highlight the clinical significance and management challenges of this condition.
Main Methods:
- Review of pathogenic mechanisms including vascular reactivity, immunosuppressant effects (cyclosporine [CSA], FK506), renal function (glomerular filtration rate [GFR]), sodium excretion, and steroid impact.
- Discussion of clinical implications for cardiovascular risk and patient management.
Main Results:
- Altered vascular reactivity and vasoconstriction due to CSA and FK506 are primary contributors.
- Impaired GFR and sodium excretion, along with steroid effects, exacerbate hypertension.
- This condition significantly increases long-term cardiovascular risk for liver transplant recipients.
Conclusions:
- Acquired hypertension post-liver transplant is multifactorial.
- Timely recognition and intervention are critical for managing transplant recipients' cardiovascular health.
Abstract:
Hypertension developing after liver transplantation is nearly universal and likely reflects several pathogenic mechanisms. Foremost among these are altered vascular reactivity and vasoconstriction related to CSA, and probably FK506, administration, impaired GFR and sodium excretion, and the effects of steroids. This disorder is of both theoretical and practical importance in understanding blood pressure regulation in humans. Most importantly, it poses a considerable long-term cardiovascular risk for the transplant recipient. Recognition of acquired hypertension and timely intervention are among the primary management challenges for the transplant clinician.